Filing Details

Accession Number:
0001439222-24-000058
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-07 18:49:02
Reporting Period:
2024-03-05
Accepted Time:
2024-03-07 18:49:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1439222 Agios Pharmaceuticals Inc. AGIO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1312622 I Kaye Foster-Cheek C/O Agios Pharmaceuticals, Inc.
88 Sidney Street
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-05 300 $32.21 11,224 No 4 S Direct
Common Stock Disposition 2024-03-06 4,415 $31.99 6,809 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,200 Indirect By Foster Family Revocable Trust
Footnotes
  1. The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $31.99 to $32.04. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.